TransMedics Group, Inc. TMDX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $635.89M+30.2% | $605.49M+37.1% | $566.35M+41.2% | $531.29M+48.1% | $488.23M+64.4% | ||
| $260.15M+31.5% | $242.69M+35.2% | $224.95M+37.9% | $213.62M+51.6% | $197.88M+77.3% | ||
| $375.74M+29.4% | $362.81M+38.4% | $341.41M+43.5% | $317.68M+45.9% | $290.35M+56.7% | ||
| 59.1%-0.4pp | 59.9%+0.6pp | 60.3%+0.9pp | 59.8%-0.9pp | 59.5%-2.9pp | ||
| $76.77M+24.3% | $69.06M+23.4% | $64.82M+29.0% | $63.82M+35.4% | $61.75M+48.6% | ||
| $204.53M+16.2% | $185.17M+9.8% | $180.63M+15.6% | $177.27M+22.9% | $176.08M+34.7% | ||
| $281.3M+18.3% | $254.22M+13.2% | $245.45M+18.8% | $241.1M+10.3% | $237.83M+19.2% | ||
| $281.3M+18.3% | $254.22M+13.2% | $245.45M+18.8% | $241.1M+10.3% | $237.83M+19.2% | ||
| $94.44M+79.8% | $108.58M+190% | $95.95M+233% | $76.58M+2,348% | $52.52M+412% | ||
| 14.9%+4.1pp | 17.9%+9.4pp | 16.9%+9.7pp | 14.4%+15.4pp | 10.8%+16.4pp | ||
| $17.49M+22.6% | $13.78M-4.4% | $14M-3.1% | $14.13M-2.0% | $14.27M+7.3% | ||
| —— | —— | -$3.08M-357% | -$2.49M-209% | -$2.46M-196% | ||
| $89.33M+78.4% | $107.52M+201% | $92.88M— | $74.09M— | $50.06M— | ||
| -$82.59M-7,514% | -$82.77M-26,293% | $1.11M+6,856% | $2.43M+260% | $1.11M+176% | ||
| $171.92M+251% | $190.29M+437% | $91.77M— | $71.66M— | $48.95M— | ||
| 27%+17.0pp | 31.4%+23.4pp | 16.2%— | 13.5%— | 10%— | ||
| $4.37+219% | $4.87+377% | $2.48— | $1.94— | $1.37— | ||
| $5.05+244% | $5.60+419% | $2.71— | $2.13— | $1.47— | ||
| 158M+8.2% | 161.8M+14.8% | 156.4M+13.2% | 151.4M+12.0% | 146.1M+10.4% | ||
| 136.4M+2.2% | 135.7M+2.4% | 135M+2.4% | 134.3M+2.5% | 133.5M+2.4% | ||
| $12.39M+4.8% | $12.72M+0.2% | $10.92M-30.2% | $11.64M-30.3% | $11.82M-25.5% | ||
| $94.44M+79.8% | $108.58M+190% | $95.95M+233% | $76.58M+2,348% | $52.52M+412% | ||
| $127.35M+71.8% | $135.77M+137% | $121.35M+161% | $100.3M+812% | $74.11M+1,417% | ||
| $127.35M+71.8% | $135.77M+137% | $121.35M+161% | $100.3M+812% | $74.11M+1,417% | ||
| 20%+4.8pp | 22.4%+9.5pp | 21.4%+9.8pp | 18.9%+15.8pp | 15.2%+17.1pp | ||
| $94.44M+79.8% | $108.58M+190% | $95.95M+233% | $76.58M+2,348% | $52.52M+412% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is TransMedics Group, Inc.'s revenue?
- TransMedics Group, Inc. (TMDX) generated $635.9M in revenue over the trailing twelve months, up 30.2% year over year.
- Is TransMedics Group, Inc. profitable?
- TransMedics Group, Inc. reported $171.9M in net income over the trailing twelve months, a 27.0% net margin.
- What are TransMedics Group, Inc.'s profit margins?
- Gross margin is 59.1% and operating margin is 14.9%, with a 27.0% net margin.
- What is TransMedics Group, Inc.'s earnings per share?
- TransMedics Group, Inc.'s diluted EPS over the trailing twelve months is $4.37.
- Where does TransMedics Group, Inc.'s income statement data come from?
- Every line is extracted from TransMedics Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
